Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Xiaofen Li, Xia Li, Xuefeng Fang, Ying Yuan
  • OncoTargets and Therapy, July 2018, Dove Medical Press
  • DOI: 10.2147/ott.s154567

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication


The following have contributed to this page: Ying Yuan